Monthly Archives: April 2019
Coronary artery wall thickness a heart disease marker in women
Coronary wall thickness, as measured by MRI, is a promising tool for early detection of coronary artery disease
The thickness of the coronary artery wall...
High-calorie diet during stress may lead to more weight gain
A high-calorie diet during stress results in more weight gain than the same diet in a stress-free environment
Under stress, watching what you eat may...
Mission Delhi: ICMR launches pilot for paramedics on bikes
During the pilot of Mission Delhi, two bike borne paramedics will provide services to heart patients within a 3 Km radius of AIIMS
Get set...
Between 2010-17, 2.9 mn Indian kids missed out on measles vaccine
UNICEF estimates that 169 million children, of them, 2.9 million in India, missed out on the first dose of the measles vaccine between 2010...
Non-antibiotic combos work in long-term acne treatment
Non-antibiotic combinations are being preferred by doctors in long-term acne treatment, finds new research
Physicians are scaling back on prescribing antibiotics for long-term acne treatment...
Long use of antibiotics can increase stroke risk in women
Study shows that women who take antibiotics for a long time are at a higher risk of stroke and cardiovascular diseases
Women who take antibiotics...
World’s 1st malaria vaccine pilots in Malawi; Kenya Ghana next
The first ever malaria vaccine is piloting in Malawi, could change the malaria landscape
The world's first malaria vaccine is piloting in Malawi. The country...
USFDA approves device to treat attention deficit disorder (ADHD)
USFDA has approved a device to treat attention deficit hyperactivity disorder (ADHD)
In a first, a medical device that can treat attention deficit hyperactivity disorder...
Deworming programs safe – do not alter gut microflora
No major differences between the gut bacteria of people infected with roundworm or hookworm and uninfected peers, finds study
A new study has identified no...
Hilleman Laboratories to develop and market ICMR’s Shigella vaccine
ICMR has licensed the Shigella vaccine technology for further scaling up and commercialisation to Hilleman Laboratories
Hilleman Laboratories will market the Shigella vaccine developed by...
